TrialJournal of hematology & oncology2013

A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease.

Ted Wun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.